Skyemed, Inc. v. Skyemed-Orlando, Inc. et. al.
Lan Kennedy-Davis represented Defendant Greenhouse, who was the CEO of Skyemed-Orlando, Inc. This case was litigated in both state court and federal court. This cases involved a dispute between 50/50 shareholders of a pharmaceutical company initially valued between $15 million to $20 million. The parties both filed derivative actions against the other in state court and a trademark infringement action was filed by Plaintiff in the United States District Court, Middle District of Florida. Plaintiff sought the Court’s appointment of a receiver for the corporation which Lan Kennedy-Davis successfully prevented. All of Plaintiff’s motions heard by the court was denied. Plaintiff dismissed the federal court case with prejudice. Plaintiff agreed to sell his shares to Defendant for a small fraction of the value of the business to settle the case.